Success Metrics

Clinical Success Rate

100.0%

Based on 5 completed trials

Completion Rate

100%(5/5)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

N/ANon-phased studies

5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials

Showing 5 of 5

completednot_applicable

FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

NCT05810025

completednot_applicable

Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting

NCT03069742

completednot_applicable

Clinical Trials (5)

Showing 5 of 5 trials

NCT05810025Not Applicable

FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments

Completed

NCT03069742Not Applicable

Study of Web-based Decision Aids for Increasing Breast Cancer Chemoprevention in the Primary Care Setting

Completed

NCT03470402Not Applicable

Decision Support for BRCA Testing in Ethnically Diverse Women

Completed

NCT02954900Not Applicable

Know Your Risk: Assessment at Screening for Breast Cancer - Pilot Study

Completed

NCT03624088Not Applicable

CBPR - BRCA Genetic Testing Among Orthodox Jews

Completed

All 5 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 5